Phoenix Financial Ltd. 13D and 13G filings for Teva Pharmaceutical Industries Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-22 09:25 am Purchase | 2025-07-14 | 13G | Teva Pharmaceutical Industries Limited TEVA | Phoenix Financial Ltd. | 57,383,158 5.000% | 3,238,161 (+5.98%) | Filing |
| 2024-04-09 10:26 am Purchase | 2024-04-01 | 13G | Teva Pharmaceutical Industries Limited TEVA | Phoenix Financial Ltd. | 54,144,997 4.830% | 54,144,997 (New Position) | Filing |